Cancer drug improves survival in patients with metastatic melanoma
The University of Arizona Cancer Center.
(Medical Xpress)—Results of a University of Arizona Cancer Center's scientist-led clinical trial show that a drug already approved for breast and lung cancer improved progression-free survival in patients with metastatic melanoma.
The findings of the Phase III study of nab-paclitaxel, brand name Abraxane, therapy compared to standard dacarbazine therapy were presented at the Society for Melanoma Research in California Nov. 11.
Dr. Evan Hersh, a professor of medicine at the UA College of Medicine, said the UACC was the site of the initial Phase I and II studies when researchers first detected activity of nab-paclitaxel in melanoma patients. The drug, originally developed by Abraxis BioScience, later was acquired by Celgene Corporation. Hersh said he chaired a Phase II study, which showed activity in patients that had one or two previous treatments for their melanoma as well as others who had a more intensive treatment for their disease. Hersh then chaired the Phase III study with Celgene.
Melanoma is the most serious form of skin cancer, and while it occurs less often than non-melanoma skin cancers, it causes more deaths. There have been no chemotherapy drugs approved for metastatic melanoma since 1975; however, there has been considerable progress with so-called targeted therapy and with immunotherapy.
"Metastatic melanoma presents significant treatment challenges due in part to limited therapies, low survival rates at diagnosis and no advances in chemotherapy in 37 years," Hersh said. "Despite advances with targeted treatment and immunotherapies, there is still a need for new agents including chemotherapy treatments for patients with metastatic melanoma as the long term survival of patients with metastatic disease is poor."
In the Phase III study, a randomized, open-label multicenter multinational study, nab-paclitaxel showed a statistically significant improvement in median progression-free survival in chemotherapy-naïve patients with metastatic melanoma compared to patients receiving dacarbazine chemotherapy (4.8 versus 2.5 months). An interim analysis of overall survival, the secondary endpoint, shows a trend in favor of the nab-paclitaxel arm compared to treatment with dacarbazine (12.8 and 10.7 months, respectively).
Hersh said it is hoped that nab-paclitaxel and other agents under development will eventually provide a major improvement in the survival of melanoma patients with spread throughout the body.
The melanoma program of the UACC consists of a team of medical, dermatological, surgical and radiation oncologists as well as a group of basic scientists who are devoted to development of an improved understanding, prevention and treatment of all stages of malignant melanoma.
Provided by University of Arizona
- ASCO: Trametinib improves survival in metastatic melanoma Jun 05, 2012 | not rated yet | 0
- Combination treatment regimen not effective against advanced melanoma Jun 05, 2010 | not rated yet | 0
- New drug, Vemurafenib, doubles survival of metastatic melanoma patients Mar 01, 2012 | not rated yet | 0
- Research shows promising treatments against skin cancer Jun 04, 2012 | not rated yet | 0
- New drug for metastatic melanoma shows promising results in clinical trial Nov 11, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be villous adenoma in colon, if there are no villi there
5 hours ago As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
- More from Physics Forums - Medical Sciences
More news stories
Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.
Cancer 3 hours ago | not rated yet | 0
Cancer survivors are no more likely to stop smoking, cut down on alcohol, or exercise more often than the general population, according to new research published in the British Journal of Cancer today (Wednesday)
Cancer 4 hours ago | not rated yet | 0
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Jo ...
Cancer 5 hours ago | not rated yet | 0
A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, non-surgical, short-term radiation therapy for breast cancer.
Cancer 5 hours ago | 5 / 5 (1) | 0
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Cancer 18 hours ago | not rated yet | 0
Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe ...
41 minutes ago | not rated yet | 0 |
Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with ...
41 minutes ago | not rated yet | 0 |
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
41 minutes ago | not rated yet | 0
University of Granada scientists have patented a new treatment for acne that is based on completely natural substances and is much more effective than artificial formulas because it does not create resistance ...
48 minutes ago | not rated yet | 0
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
1 hour ago | not rated yet | 0
(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...
4 hours ago | not rated yet | 0 |